Glucose Health (OTCMKTS:GLUC) Shares Down 13.7% – Should You Sell?

Shares of Glucose Health, Inc. (OTCMKTS:GLUC) were down 13.7% during mid-day trading on Thursday . The stock traded as low as $0.39 and last traded at $0.4143. Approximately 29,379 shares were traded during trading, a decline of 5% from the average daily volume of 30,786 shares. The stock had previously closed at $0.4798.

Key Stories Impacting Glucose Health

Here are the key news stories impacting Glucose Health this week:

• Positive Sentiment: Experts calling for earlier diabetes screening as youth cases rise could expand demand for home and wearable glucose-monitoring solutions, supporting long-term market growth that benefits small CGM players like GLUC. Experts call for early diabetes checks as youth cases rise
• Positive Sentiment: Large device makers (Insulet, Abbott, Dexcom) highlighting Type 2 diabetes at the ATTD conference signals validation and commercialization focus for CGMs beyond Type 1 — a market expansion that could increase overall adoption and benefit challengers if GLUC can differentiate on price, distribution or features. Insulet, Abbott, Dexcom set sights on Type 2 diabetes at ATTD
• Positive Sentiment: First‑hand consumer stories and coverage about using glucose monitors (e.g., personal wear‑test pieces) increase public interest and could drive retail demand and trial adoption for consumer-focused CGM offerings. I wore a glucose monitor for 2 weeks. Here’s what I learnt about my diet
• Neutral Sentiment: New diagnostic ideas (a saliva test claiming to reveal hidden diabetes risk) and lifestyle‑focused coverage (diet, walking, sunlight) keep diabetes in the news and sustain consumer attention but don’t directly change device competitive dynamics. Scientists Discover Simple Saliva Test That Reveals Hidden Diabetes Risk
• Neutral Sentiment: Industry recognition (ADA awards) and general health items maintain sector visibility but are unlikely to move GLUC’s stock on their own. The American Diabetes Association Announces the 2026 National Scientific and Health Care Achievement Award Winners
• Negative Sentiment: An Abbott glucose‑monitor recall linked in reporting to several deaths is weighing on trust in continuous glucose monitors broadly and could prompt regulatory scrutiny, tighter labeling/clearance requirements, or slower adoption — a near‑term negative for small CGM vendors like GLUC. Diabetics who rely on glucose monitors are alarmed by recall linked to 7 deaths

Glucose Health Stock Performance

The firm has a market capitalization of $8.47 million, a price-to-earnings ratio of -13.81 and a beta of 1.26. The company has a fifty day moving average of $0.31 and a two-hundred day moving average of $0.18.

Glucose Health Company Profile

Glucose Health, Inc engages in the formulation, manufacturing, marketing, and distribution of soluble fiber infused nutritional beverages. It offers soluble fiber infused powdered iced tea, and flavored drink mixes for pre-diabetic and diabetic persons under the GLUCODOWN brand in North America. The company was formerly known as Bio-Solutions Corp. and changed its name to Glucose Health, Inc in November 2014. Glucose Health, Inc was incorporated in 2007 and is based in Bentonville, Arkansas.